On August 7, 2009, US Senator Sheldon Whitehouse (D-RI) announced the introduction of legislation aimed at giving US consumers better recourse against foreign manufacturers that sell defective products to the United States. The Foreign Manufacturers Legal Accountability Act of 2009 is in response to a May hearing held by the Senate Judiciary Subcommittee on Administrative Oversight and the Courts, during which witnesses testified about the delays and expense associated with serving foreign manufacturers with a lawsuit and establishing jurisdiction in US courts. The bill would lower these barriers by requiring federal agencies, such as the US Food and Drug Administration (“FDA”), to pass regulations mandating that regulated foreign manufacturers register an agent who will accept service of process. The bill would also make clear to foreign manufacturers that by importing their products into the United States, and by registering an agent in the United States, they are consenting to the jurisdiction of the courts in the state where their agent is located. Manufacturers who only import a minimal amount of products into the United States could be exempt from these requirements at the discretion of the federal agencies. Senator Whitehouse contends that this approach complies with Article 3 of the General Agreement on Tariffs and Trade (“GATT”), which requires that imports be treated no less favorably than the same or similar domestically-produced goods after they have passed customs, because American manufacturers are subject to the jurisdiction of the courts of at least one state.